Correlation Between Citigroup and Moleculin Biotech
Can any of the company-specific risk be diversified away by investing in both Citigroup and Moleculin Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and Moleculin Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citigroup and Moleculin Biotech, you can compare the effects of market volatilities on Citigroup and Moleculin Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of Moleculin Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and Moleculin Biotech.
Diversification Opportunities for Citigroup and Moleculin Biotech
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Citigroup and Moleculin is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and Moleculin Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moleculin Biotech and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with Moleculin Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moleculin Biotech has no effect on the direction of Citigroup i.e., Citigroup and Moleculin Biotech go up and down completely randomly.
Pair Corralation between Citigroup and Moleculin Biotech
Taking into account the 90-day investment horizon Citigroup is expected to generate 0.3 times more return on investment than Moleculin Biotech. However, Citigroup is 3.39 times less risky than Moleculin Biotech. It trades about 0.21 of its potential returns per unit of risk. Moleculin Biotech is currently generating about 0.03 per unit of risk. If you would invest 6,360 in Citigroup on August 29, 2024 and sell it today you would earn a total of 615.00 from holding Citigroup or generate 9.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Citigroup vs. Moleculin Biotech
Performance |
| Timeline |
| Citigroup |
| Moleculin Biotech |
Citigroup and Moleculin Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Citigroup and Moleculin Biotech
The main advantage of trading using opposite Citigroup and Moleculin Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, Moleculin Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moleculin Biotech will offset losses from the drop in Moleculin Biotech's long position.The idea behind Citigroup and Moleculin Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Moleculin Biotech vs. Eliem Therapeutics | Moleculin Biotech vs. Scpharmaceuticals | Moleculin Biotech vs. Milestone Pharmaceuticals | Moleculin Biotech vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |